Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on April 30, 2025
Présentation des résultats d’une collaboration de recherche en Immuno-Oncologie avec le Centre Léon Bérard - Au congrès annuel de l’AACR 2025
GlobeNewswire
·
April 30, 2025
Présentation des résultats d’une collaboration de recherche en Immuno-Oncologie avec le Centre Léon Bérard Au congrès annuel de l’AACR 2025 Une nouvelle signature d’expression génique pour prédire la réponse clinique aux points de contrôle immunitaires …
Nicox Provides Full Year 2024 Financial Results
GlobeNewswire
·
April 30, 2025
Nicox SA revenue of €7.9 million for full year 2024 Exceptional income of €13.7 million following the transfer of VYZULTA’s future revenue stream to Soleus Capital Nicox SA cash of €10.5 million on 31 December 2024 and the Company estimates it is …
Nicox : Résultats financiers de l’année 2024
GlobeNewswire
·
April 30, 2025
Chiffre d’affaires de Nicox SA de 7,9 millions d’euros pour l’année 2024 Produits exceptionnels de 13,7 millions d’euros suite à la cession du flux futur de redevances de VYZULTA au fond Soleus Capital Trésorerie de Nicox SA au 31 décembre 2024 de 10,5 …
Technip Energies First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
TECHNIP ENERGIES Q1 2025 FINANCIAL RESULTS A strong company in any scenario Significant growth in the first quarter: Revenue +22% Y/Y to €1.85bn and Recurring EBITDA +19% Y/Y €162m 2025 Group guidance confirmed with segment revenues updated and …
Resultats Financiers de Technip Energies du Premier Trimestre 2025
GlobeNewswire
·
April 30, 2025
RÉSULTATS FINANCIERS DE TECHNIP ENERGIES DU PREMIER TRIMESTRE 2025 Une entreprise solide quel que soit le scénario Forte croissance au premier trimestre : chiffre d'affaires en hausse de 22 % à 1,85 milliard d'euros et EBITDA récurrent en hausse de …
Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO
GlobeNewswire
·
April 30, 2025
Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO New recruits expand senior team capabilities as the business progresses its lead HDAC6 inhibitor program, AGT-100216, into the clinic for the …
Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
GlobeNewswire
·
April 30, 2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 30, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
GlobeNewswire
·
April 30, 2025
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Q1 2025 net sales of USD 2,480 million up by 3% in constant currencies (cc); stable in USD up by 5%[1] at a comparable growth rate (CGR), when adjusted for impact of …
ArcelorMittal S.A.: ArcelorMittal reports first quarter 2025
GlobeNewswire
·
April 30, 2025
Luxembourg, April 30, 2025 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for …
Nexans - Q1 2025, promising start to the year
GlobeNewswire
·
April 30, 2025
First-quarter 2025 financial information Promising start to 2025 Electrification segment, a key driver of our growth, delivering +6.8% organic growth in Q1 2025 No material impact from “US Liberation Day” Tariff 2025 guidance confirmed First-quarter 2025 …
Nexans - T1 2025, un début d'année prometteur
GlobeNewswire
·
April 30, 2025
Information financière du premier trimestre 2025 Un début d’année prometteur pour 2025 Segment Électrification : un moteur clé de notre croissance, avec +6,8 % de croissance organique au T1 2025 Aucun impact significatif lié au tarif du “US Liberation Day” …
Equinor to commence second tranche of the 2025 share buy-back programme
GlobeNewswire
·
April 30, 2025
Equinor (OSE: EQNR, NYSE: EQNR) will after the annual general meeting 14 May 2025 commence the second tranche of up to USD 1,265 million of the share buy-back programme for 2025, as announced in relation with the first quarter results 30 April 2025. …
Equinor vil starte andre transje av tilbakekjøpsprogrammet for aksjer for 2025
GlobeNewswire
·
April 30, 2025
Equinor (OSE: EQNR, NYSE: EQNR) vil etter generalforsamlingen 14. mai 2025 starte andre transje av tilbakekjøpsprogrammet for aksjer for 2025 på inntil 1.265 millioner USD, som annonsert i forbindelse med selskapets første kvartalsresultat 30. april 2025. …
Equinor ASA: Key information relating to cash dividend for first quarter 2025
GlobeNewswire
·
April 30, 2025
Key information relating to the cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for first quarter 2025. Cash dividend amount: 0.37 Announced currency: USD Last day including rights: 15 August 2025 Ex-date Oslo Børs : 18 August 2025 Ex-date New …
Equinor ASA: Nøkkelinformasjon angående kontantutbytte for første kvartal 2025
GlobeNewswire
·
April 30, 2025
Nøkkelinformasjon angående kontantutbytte for Equinor (OSE: EQNR, NYSE: EQNR) for første kvartal 2025. Utbyttebeløp: 0,37 Annonsert valuta: USD Siste dag inklusive: 15. august 2025 Ex-dato Oslo Børs: 18. august 2025 Ex-dato New York Stock Exchange: 19. …
Equinor first quarter 2025 results
GlobeNewswire
·
April 30, 2025
Equinor (OSE:EQNR, NYSE:EQNR) delivered adjusted operating income* of USD 8.65 billion and USD 2.25 billion after tax in the first quarter of 2025. Equinor reported net operating income of USD 8.87 billion and net income at USD 2.63 billion. Adjusted net …
Equinors resultater for første kvartal 2025
GlobeNewswire
·
April 30, 2025
Equinor (OSE:EQNR, NYSE:EQNR) leverte et justert driftsresultat* på 8,65 milliarder USD og 2,25 milliarder USD etter skatt i første kvartal 2025. Det rapporterte driftsresultatet var 8,87 milliarder USD, og resultatet for perioden var 2,63 milliarder USD. …
Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel
GlobeNewswire
·
April 30, 2025
VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to …
Orca Energy Group Inc. Announces 2024 Year End Audited Financial Results
GlobeNewswire
·
April 30, 2025
TORTOLA, British Virgin Islands, April 29, 2025 (GLOBE NEWSWIRE) -- Orca Energy Group Inc. ("Orca" or "the Company" and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today announced its audited financial results for the fourth quarter (" …
Divine Supplements EDEN Under Review: Biblical Secret Reveals Soluble Psyllium Husk Fiber Formula for Toxic Lymphatic System Support
GlobeNewswire
·
April 30, 2025
New York, April 29, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: How the Divine Supplements EDEN formula draws inspiration from biblical health secrets to support modern wellness. Why soluble psyllium husk fiber plays a vital role in natural …